SOX17 Enables Immune Evasion of Early Colorectal Adenomas and Cancers

To understand this process in early colorectal cancers, scientists investigated how naive colon cancer organoids that were engineered in vitro to harbor Apc-null, KrasG12D and Trp53-null mutations adapted to the in vivo native colonic environment.